ISSN: 1859 - 2872
Drug-associated bullous pemphigoid with combination antihypertensive drug tolucombi (telmisartan and hydrochlorothiazide): A case report
Main Article Content
Keywords
Abstract
Bullous pemphigoid is an autoimmune subepidermal blistering disease, chronic progression and occurs primarily skin, mucosal invovelment is not frequent. This condition is more common in the elderly with a male and female ratio of 1:1. Drug-associative bullous pemphigoid (DABP) is a term used to describe instances of bullous pemphigoid demonstrating clinical, histological, or immunopathological features identical or similar to those of the idiopathic form of bullous pemphigoid, related to the systemic ingestion, or topical application. We report a case of a female patient with acute and multiform lesions: Erythema, vesicles, bullous, and fever after taking an antihypertensive drug containing telmisartan and hydrochlorothiazide. Basing on clinical features, histopathology and direct immunofluorescence we confirmed the diagnosis
Article Details
References
2. Schiavo AL et al (2013) Bullous pemphigoid: Etiology, pathogenesis, and inducing factors: Facts and controversies. Clin Dermatol 31(4): 391-399.
3. Warner C et al (2014) Bullous pemphigoid induced by hydrochlorothiazide therapy. J Drugs Dermatol 13(3): 360-362.
4. Cozzanin E et al (2015) Atypical presentations of bullous pemphigoid: Clinical and immunopathological aspects. Autoimmun Rev 14(5): 438-445.
5. Moro F, Fania L, Sinagra JLM (2020) Bullous pemphigoid: Trigger and predisposing factors. Biomolecules 10(10): 1432.
6. Verheyden MJ, Bilgic A, Murrell DF (2020) A systematic review of drug-induced pemphigoid. Acta Derm Venereol 100(15).
7. García Sanchez VC et al (2013) Hydrochlorothiazide induced bullous pemphigoid. Semergen 39(4): 214-217.
Article Sidebar
